A study from Karolinska Institutet, published in Allergy, finds that biologic drugs for severe asthma may not fully eliminate inflammatory immune cells. These cells can increase during treatment, possibly causing symptoms to return once therapy stops. Experts stress the need for ongoing treatment and further research on long-term effects.